390 related articles for article (PubMed ID: 26640409)
1. Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.
Kim S; Kim SJ; Yoon HE; Chung S; Choi BS; Park CW; Shin SJ
Int J Med Sci; 2015; 12(11):891-904. PubMed ID: 26640409
[TBL] [Abstract][Full Text] [Related]
2. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW
Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 deficiency promotes the progression from acute tubular damage to chronic renal fibrosis following unilateral ureteral obstruction.
Kong W; Fu J; Liu N; Jiao C; Guo G; Luan J; Wang H; Yao L; Wang L; Yamamoto M; Pi J; Zhou H
Nephrol Dial Transplant; 2018 May; 33(5):771-783. PubMed ID: 29126308
[TBL] [Abstract][Full Text] [Related]
4. Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.
Chung S; Kim S; Kim M; Koh ES; Shin SJ; Park CW; Chang YS; Kim HS
PLoS One; 2017; 12(7):e0181757. PubMed ID: 28753620
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction.
Moriyama T; Kawada N; Ando A; Yamauchi A; Horio M; Nagata K; Imai E; Hori M
Kidney Int; 1998 Jul; 54(1):110-9. PubMed ID: 9648069
[TBL] [Abstract][Full Text] [Related]
6. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
Wang W; Ma BL; Xu CG; Zhou XJ
Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats.
Gounder VK; Arumugam S; Arozal W; Thandavarayan RA; Pitchaimani V; Harima M; Suzuki K; Nomoto M; Watanabe K
Int Immunopharmacol; 2014 Feb; 18(2):282-9. PubMed ID: 24291173
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Necroptosis Attenuates Kidney Inflammation and Interstitial Fibrosis Induced By Unilateral Ureteral Obstruction.
Xiao X; Du C; Yan Z; Shi Y; Duan H; Ren Y
Am J Nephrol; 2017; 46(2):131-138. PubMed ID: 28723681
[TBL] [Abstract][Full Text] [Related]
9. Nigella sativa extract is a potent therapeutic agent for renal inflammation, apoptosis, and oxidative stress in a rat model of unilateral ureteral obstruction.
Hosseinian S; Ebrahimzadeh Bideskan A; Shafei MN; Sadeghnia HR; Soukhtanloo M; Shahraki S; Samadi Noshahr Z; Khajavi Rad A
Phytother Res; 2018 Nov; 32(11):2290-2298. PubMed ID: 30070029
[TBL] [Abstract][Full Text] [Related]
10. Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction.
Le Y; Zheng Z; Xue J; Cheng M; Guan M; Xue Y
J Renin Angiotensin Aldosterone Syst; 2016 Oct; 17(4):. PubMed ID: 27913661
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation.
Wang Y; Wang B; Du F; Su X; Sun G; Zhou G; Bian X; Liu N
Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):164-72. PubMed ID: 25625183
[TBL] [Abstract][Full Text] [Related]
12. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.
Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW
J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane protects from kidney damage during the release of unilateral ureteral obstruction (RUUO) by activating nuclear factor erythroid 2-related factor 2 (Nrf2): Role of antioxidant, anti-inflammatory, and antiapoptotic mechanisms.
Aranda-Rivera AK; Cruz-Gregorio A; Amador-Martínez I; Medina-Campos ON; Garcia-Garcia M; Bernabe-Yepes B; León-Contreras JC; Hernández-Pando R; Aparicio-Trejo OE; Sánchez-Lozada LG; Tapia E; Pedraza-Chaverri J
Free Radic Biol Med; 2024 Feb; 212():49-64. PubMed ID: 38141891
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 signaling attenuates epithelial-to-mesenchymal transition and renal interstitial fibrosis via PI3K/Akt signaling pathways.
Wang J; Zhu H; Huang L; Zhu X; Sha J; Li G; Ma G; Zhang W; Gu M; Guo Y
Exp Mol Pathol; 2019 Dec; 111():104296. PubMed ID: 31449784
[TBL] [Abstract][Full Text] [Related]
15. Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2.
Chung S; Yoon HE; Kim SJ; Kim SJ; Koh ES; Hong YA; Park CW; Chang YS; Shin SJ
Nutr Metab (Lond); 2014 Jan; 11(1):2. PubMed ID: 24393202
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome.
Wang W; Luo R; Lin Y; Wang F; Zheng P; Levi M; Yang T; Li C
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F910-22. PubMed ID: 25694485
[TBL] [Abstract][Full Text] [Related]
17. The Protective Effect of Ursolic Acid on Unilateral Ureteral Obstruction in Rats by Activating the Nrf2/HO-1 Antioxidant Signaling Pathway.
Pei J; Wu M; Cai S; Peng J; Zhan X; Wang D; Wang W; An N
Comput Intell Neurosci; 2022; 2022():3690524. PubMed ID: 36059402
[TBL] [Abstract][Full Text] [Related]
18. T-type calcium channel blocker attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis by activating the Nrf2 antioxidant pathway.
Chung S; Kim S; Kim M; Koh ES; Yoon HE; Kim HS; Park CW; Chang YS; Shin SJ
Am J Transl Res; 2016; 8(11):4574-4585. PubMed ID: 27904663
[TBL] [Abstract][Full Text] [Related]
19. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK
PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel angiotensin II receptor type I antagonist, fimasartan on myocardial ischemia/reperfusion injury.
Han J; Park SJ; Thu VT; Lee SR; Long le T; Kim HK; Kim N; Park SW; Jeon ES; Kim EJ; Yoon CH; Cho GY; Choi DJ
Int J Cardiol; 2013 Oct; 168(3):2851-9. PubMed ID: 23642815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
